使用直接观察治疗法评估貌似难治性高血压患者的治疗依从性。
Use of Directly Observed Therapy to Assess Treatment Adherence in Patients With Apparent Treatment-Resistant Hypertension.
作者信息
Ruzicka Marcel, Leenen Frans H H, Ramsay Tim, Bugeja Ann, Edwards Cedric, McCormick Brendan, Hiremath Swapnil
机构信息
Renal Hypertension Center, Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada.
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
出版信息
JAMA Intern Med. 2019 Oct 1;179(10):1433-1434. doi: 10.1001/jamainternmed.2019.1455.
Abstract
This cohort study evaluates the association of directly observed therapy with treatment adherencee in patients with apparent treatment-resistant hypertension.
摘要
这项队列研究评估了直接观察治疗与明显难治性高血压患者治疗依从性之间的关联。
相似文献
1
Use of Directly Observed Therapy to Assess Treatment Adherence in Patients With Apparent Treatment-Resistant Hypertension.使用直接观察治疗法评估貌似难治性高血压患者的治疗依从性。
JAMA Intern Med. 2019 Oct 1;179(10):1433-1434. doi: 10.1001/jamainternmed.2019.1455.
2
Adherence to medication and drug monitoring in apparent treatment-resistant hypertension.在明显的难治性高血压中坚持药物治疗和药物监测。
Blood Press. 2016 Aug;25(4):199-205. doi: 10.3109/08037051.2015.1121706. Epub 2016 Jan 5.
3
Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic.在顽固性高血压患者中，不坚持服用抗高血压药物的情况非常普遍：直接观察治疗诊所的结果。
J Hum Hypertens. 2016 Feb;30(2):83-9. doi: 10.1038/jhh.2015.38. Epub 2015 May 7.
4
Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial.明显难治性高血压患者的药物依从性：SYMPATHY 试验的结果。
Br J Clin Pharmacol. 2018 Jan;84(1):18-24. doi: 10.1111/bcp.13402. Epub 2017 Oct 10.
5
Improvement of Blood Pressure Control by Adherence Check in Patients With Apparent Treatment-Resistant Hypertension: A Case Series.通过依从性检查改善貌似难治性高血压患者的血压控制：病例系列
Clin Med Insights Case Rep. 2020 Feb 17;13:1179547620904884. doi: 10.1177/1179547620904884. eCollection 2020.
6
Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary care.评估爱尔兰初级保健中明显治疗抵抗性高血压患者的治疗依从性：一项可行性研究。
Br J Gen Pract. 2019 Aug 29;69(686):e621-e628. doi: 10.3399/bjgp19X705077. Print 2019 Sep.
7
Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis.明显治疗抵抗性高血压患者的药物依从性：系统评价与荟萃分析
J Hypertens. 2017 Dec;35(12):2346-2357. doi: 10.1097/HJH.0000000000001502.
8
Resistant hypertension? Assessment of adherence by toxicological urine analysis.耐药性高血压？毒理学尿液分析评估依从性。
J Hypertens. 2013 Apr;31(4):766-74. doi: 10.1097/HJH.0b013e32835e2286.
9
Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in 3 Nonadherent Patients.治疗药物监测评估假设耐药性高血压患者的药物依从性：与 3 名不依从患者的直接观察治疗的比较。
J Cardiovasc Pharmacol. 2018 Aug;72(2):117-120. doi: 10.1097/FJC.0000000000000602.
10
Is there any Hope for Monitoring Adherence in an Efficient and Feasible Way for Resistant Hypertension Diagnosis and Follow-Up?对于难治性高血压的诊断和随访，是否有希望以高效且可行的方式监测依从性？
Curr Hypertens Rep. 2020 Oct 14;22(11):96. doi: 10.1007/s11906-020-01105-6.
引用本文的文献
1
Chemical adherence testing in the clinical management of hypertension: a scoping review.高血压临床管理中的化学黏附测试：一项范围综述
Front Pharmacol. 2024 Nov 6;15:1452464. doi: 10.3389/fphar.2024.1452464. eCollection 2024.
2
Emerging RNAi Therapies to Treat Hypertension.新兴的用于治疗高血压的RNA干扰疗法。
Mol Diagn Ther. 2025 Jan;29(1):25-41. doi: 10.1007/s40291-024-00747-5. Epub 2024 Oct 14.
3
Pharmacotherapeutic options for the treatment of hypertension in pregnancy.妊娠期高血压的治疗药物选择。
Expert Opin Pharmacother. 2024 Sep;25(13):1739-1758. doi: 10.1080/14656566.2024.2398602. Epub 2024 Sep 9.
4
Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran.利用 RNA 干扰降低胆固醇：Inclisiran 的从实验室到临床的故事。
J Am Heart Assoc. 2024 Mar 19;13(6):e032031. doi: 10.1161/JAHA.123.032031. Epub 2024 Mar 8.
5
RNA Interference as a Therapeutic Approach for Managing Hypertension.RNA干扰作为治疗高血压的一种方法。
Clin J Am Soc Nephrol. 2024 Feb 13;19(6):810-2. doi: 10.2215/CJN.0000000000000443.
6
Design and Implementation of an Electronic Health Record-Integrated Hypertension Management Application.电子健康记录整合型高血压管理应用的设计与实现。
J Am Heart Assoc. 2024 Jan 16;13(2):e030884. doi: 10.1161/JAHA.123.030884.
7
Measurement Tools and Utility of Hair Analysis for Screening Adherence to Antihypertensive Medication.用于筛查抗高血压药物依从性的头发分析的测量工具和效用。
Glob Heart. 2023 Mar 22;18(1):17. doi: 10.5334/gh.1191. eCollection 2023.
8
Is There Any Role for Device Therapies in Resistant Hypertension? Commentary.器械治疗在顽固性高血压中是否有作用？评论
Kidney360. 2020 Jan 2;1(1):14-15. doi: 10.34067/KID.0000682019. eCollection 2020 Jan 30.
9
Comparison of Clinical Outcomes and Safety Associated With Chlorthalidone vs Hydrochlorothiazide in Older Adults With Varying Levels of Kidney Function.比较不同肾功能水平老年患者中氯噻酮与氢氯噻嗪的临床结局和安全性。
JAMA Netw Open. 2021 Sep 1;4(9):e2123365. doi: 10.1001/jamanetworkopen.2021.23365.
10
Assessment of patient and provider attitudes towards therapeutic drug monitoring to improve medication adherence in low-income patients with hypertension: a qualitative study.评估患者和提供者对治疗药物监测的态度，以提高低收入高血压患者的药物依从性：一项定性研究。
BMJ Open. 2020 Nov 27;10(11):e039940. doi: 10.1136/bmjopen-2020-039940.
Zotero 插件